NFKB1 and hepatocellular carcinoma: In hepatocellular carcinoma models, leukemia inhibitory factor receptor deficiency enhances tumor cell resistance to ferroptosis by promoting SHP1–TRAF6 complex formation, augmenting K63‐linked ubiquitination modification, and activating NF‐κB signaling, ultimately upregulating lipocalin‐2 (LCN2) expression to significantly reduce extracellular Fe uptake capacity [193].